HIFEM (Emsella) to restore pelvic floor strength after a first vaginal birth
Official title: Effectiveness of HIFEM (High Intensity Focused Electro-Magnetic Technology) for Improving Pelvic Floor Muscle Tone in Postpartum Women: Study Protocol.
Run by Institut Investigacio Sanitaria Pere Virgili · NCT07528560 · Data updated 2026-11-12
This trial tests whether HIFEM (Emsella) treatments can help strengthen pelvic floor muscles in first-time mothers after a vaginal birth who do not have symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Institut Investigacio Sanitaria Pere Virgili Academic / other |
| Locations | 1 site (Tarragona, TARRAGONA) |
| Status | Recruiting |
| Started | April 2026 |
| Main results expected | July 1, 2026 |
| Study ends | December 2026 |
| Registry record updated | April 14, 2026 |
| Trial ID | NCT07528560 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are first-time mothers who had a single-term vaginal delivery, are 6–12 weeks postpartum, currently have no pelvic floor symptoms, and have no contraindicated implants or serious medical conditions.
✕Probably not a fit
Women who already have pelvic floor symptoms, major pelvic trauma, are pregnant or menstruating, or who have implanted electronic or metallic devices or other exclusionary health conditions are unlikely to benefit from this preventive intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a non-randomized community interventional trial comparing primiparous women who receive BTL Emsella HIFEM treatment with those who follow natural recovery after a term vaginal delivery. Eligible participants are asymptomatic, singleton, full-term mothers enrolled between 6 and 12 weeks postpartum. Pelvic floor muscle strength and structure will be measured at baseline and follow-up using clinical measures and imaging (for example, transperineal ultrasound). The trial aims to determine whether adding HIFEM leads to greater recovery of pelvic floor function than natural recovery alone.
Why it matters
Potential benefit: If successful, the treatment could restore or preserve pelvic floor strength after childbirth and lower the future risk of incontinence, prolapse, or sexual dysfunction.
How similar studies have gone: HIFEM/Emsella received FDA clearance in 2018 for urinary incontinence and prior studies have shown improvements in pelvic floor strength and incontinence symptoms, but preventive use in asymptomatic postpartum women is less well studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primiparous women * Vaginal delivery. * Single-fetus pregnancy / Singleton pregnancy. * Full-term pregnancy (\> 37 weeks of gestation). * Asymptomatic: No symptoms associated with pelvic floor muscle weakening, such as any type of incontinence or presence of prolapse. * Post-quarantine period: Between 6 and 12 weeks postpartum Exclusion Criteria: * Implanted devices: Such as pacemakers, defibrillators, or neurostimulators. * Electronic implants. * Drug delivery pumps (e.g., insulin pumps or medication infusion pumps). * Metallic implants. * Intrauterine devices (IUDs) containing any type of metal. * Application over the growth plate area. * Severe or life-threatening disorders. * Pulmonary insufficiency. * Cardiac disorders / Heart conditions. * Decompensated hemorrhagic conditions. * Decompensated blood coagulation disorders. * Malignant tumors / Malignancy. * Fever. * Epilepsy. * Menstruation * Pregnant
Where it's running
-
Centro Procrear
Tarragona, Tarragona, Spain Recruiting
Study contacts
- Principal investigator: Lys Garcia Vilaplana, Midwife. Phd Student — Universitat Rovira I Virgili. Procrear Medical Center
- Study coordinator: LYS GARCIA VILAPLANA, Lead Researcher
- Email: lys@procrear.es
- Phone: +34619357158
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
5R rehabilitation versus Swiss ball exercises for postpartum pelvic floor recovery
This trial will test whether the 5R rehabilitation program or Swiss ball exercises better improve pelvic floor strength and reduce symptoms in women within six months after childbirth who have pelvic floor muscle dysfunction.
-
Biofeedback-guided pelvic floor rehab for radiation-related sexual dysfunction after cervical cancer
This trial tests whether adding electromyographic biofeedback to pelvic floor exercises helps cervical cancer survivors see improvements in sexual function after radiotherapy.
-
Aerobic exercise and guided imagery for bowel problems after rectal cancer surgery
This study tests whether a program of aerobic exercise plus guided imagery helps people with low anterior resection syndrome after rectal cancer surgery.
-
Effect of shockwave or electromagnetic therapy with pelvic floor training on female sexual dysfunction
This trial tests whether adding shockwave therapy or pulsed electromagnetic field therapy to pelvic floor training helps women with sexual dysfunction.
-
Postpartum pelvic floor recovery and early rehabilitation after vaginal birth
This project tests whether early, individualized pelvic floor muscle training starting 2–3 weeks after a vaginal birth helps people with postpartum pelvic floor symptoms recover better than usual care.
-
Comparing core stabilization (DNS) and pelvic floor exercises for women with stress urinary leakage
This project will test whether a 12-week home program of dynamic neuromuscular stabilization (DNS) or pelvic floor muscle training (PFMT) reduces stress urinary leakage and improves quality of life for women with SUI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.